SAN FRANCISCO—If a company wants to sue a former board member for being disloyal and infringing company patents, it’s probably going to have to do so in separate courts.
That’s the takeaway from the U.S. Court of Appeals for the Federal Circuit’s decision Thursday in AngioScore v. TriReme Medical. The appellate court wiped out a medical device maker’s $20 million verdict for state-law fiduciary duty claims, saying they never should have been tied to a patent infringement suit brought in federal court.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
